Liberatore, Giuseppe http://orcid.org/0000-0003-2666-1678
De Lorenzo, Alberto
Giannotta, Claudia
Manganelli, Fiore
Filosto, Massimiliano
Cosentino, Giuseppe
Cocito, Dario
Briani, Chiara
Cortese, Andrea
Fazio, Raffaella
Lauria, Giuseppe
Clerici, Angelo Maurizio
Rosso, Tiziana
Marfia, Girolama Alessandra
Antonini, Giovanni
Cavaletti, Guido
Carpo, Marinella
Doneddu, Pietro Emiliano
Spina, Emanuele
Cotti Piccinelli, Stefano
Peci, Erdita
Querol, Luis
Nobile-Orazio, Eduardo
Article History
Received: 15 August 2021
Accepted: 4 December 2021
First Online: 20 January 2022
Change Date: 27 November 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s10072-023-07184-y
Declarations
:
: The study was approved by the Ethical Committee of each participating center. All patients gave written informed consent.
: Dr. Eduardo Nobile-Orazio reported personal fees for advisory or scientific board from Kedrion, Italy; Baxter, Italy; Novartis, Switzerland; CSL Behring, Italy; LFB, France; and Astellas, the Netherlands, outside the submitted work and travel grants to attend scientific meeting from Baxter, Grifols, Kedrion, and Novartis, Italy. Dr. Pietro Emiliano Doneddu reported travel grants to attend scientific meetings from CSL Behring and Kedrion. Dr. Giuseppe Liberatore reported travel grants to attend scientific meetings from CSL Behring and Kedrion. Dr. Dario Cocito reported honoraria for lecturing from Shire, CSL Behring, and Kedrion and travel grants to attend scientific meeting from Shire, Kedrion, and CSL Behring. Dr. Erdita Peci reported travel grants to attend scientific meetings from CSL Behring. Dr. Raffaella Fazio has served on scientific advisory boards for CSL Behring and has received travel grants from Kedrion and CSL Behring to attend scientific meeting. Dr. Marinella Carpo reported travel grants to attend scientific meetings from Kedrion. Dr. Chiara Briani has served on scientific advisory boards for Pfizer and has received travel grants from Kedrion and CSL Behring to attend scientific meeting. Dr. Giuseppe Cosentino reported travel grants to attend scientific meetings from CSL Behring and Kedrion. Dr. Andrea Cortese reported travel grants to attend scientific meetings from Kedrion. Dr. Fiore Manganelli reported personal fees for scientific events from CSL Behring and has received travel grants to attend scientific meetings from CSL Behring and Kedrion. Dr. Guido Cavaletti reported honoraria for lecturing and travel grants to attend scientific meetings from Kedrion. Dr. Massimiliano Filosto has served on scientific advisory boards for CSL Behring and Sarepta Therapeutics and has received travel grants from Sanofi-Genzyme, Kedrion, Baxter, and CSL Behring to attend scientific meeting. Dr. Girolama Alessandra Marfia reported consultancy fees and travel fundings from CSL Behring, Kedrion, Shire, and Grifols. Dr. Giovanni Antonini reported honoraria for lecturing from Kedrion and Sanofi-Genzyme, and travel grants from Kedrion, Sanofi-Genzyme, and LJ Pharma. All the other authors declare no competing interests.